Francisco Javier
López Jiménez
Profesor/a Asociado/a en CC. de la Salud
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublications en collaboration avec des chercheurs de University of Texas MD Anderson Cancer Center (2)
2024
2021
-
May ibrutinib have activity in respiratory complications by sars-cov-2? Clinical experience in a patient with chronic lymphocytic leukemia
Healthcare (Switzerland), Vol. 9, Núm. 1